Skip Navigation


JAC Advance Access originally published online on July 15, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/2/300    most recent
dkg336v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hidalgo, M.
Right arrow Articles by Arias, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hidalgo, M.
Right arrow Articles by Arias, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 52, 300-302
© 2003 The British Society for Antimicrobial Chemotherapy

Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae

Marilyn Hidalgo1,*, Elizabeth Castañeda1 and César A. Arias2

1 Microbiology Group, Instituto Nacional de Salud, Avenida Calle 26 No 51–60, Bogotá; 2 Bacterial Molecular Genetics Unit, Centro de Investigaciones, Universidad El Bosque, Bogotá, D.C., Colombia

Received 20 January 2003; returned 5 May 2003; revised 5 May 2003; accepted 15 May 2003

The present study was set up to determine vancomycin tolerance in Colombian, multiresistant, invasive, paediatric isolates of Streptococcus pneumoniae. A total of seven clinical isolates of penicillin-resistant S. pneumoniae, serotype 14, corresponding to the Spain9v-3 clone, were studied. Isolates were grown in Todd Hewitt broth at 37°C. Growth (A595) and cell viability (cfu/mL) were monitored hourly for 4 h after addition of vancomycin at 10x MIC. S. pneumoniae R6 was used as a control for growth. For R6, the mean decrease in A595 and cell viability (log10 cfu/mL) after 4 h of vancomycin treatment (in 10 independent experiments) was 95.1% and 4.2 log10, respectively. Six out of seven isolates exhibited similar behaviour. In contrast, for S. pneumoniae E239, the mean decrease in A595 and cell viability was 48.5% and 2.2 log10 after 4 h of vancomycin exposure, which suggested the presence of tolerance to vancomycin. The emergence of vancomycin-tolerant strains is of great concern in Colombia, owing to the alarming increase in resistance to penicillin.

Keywords: antimicrobial tolerance, vancomycin, Colombian isolates, killing curves, Streptococcus pneumoniae

* Corresponding author. Tel: +571-2227700 ext 446; Fax: +571-2221093; E-mail: mhidalgo{at}ins.gov.co


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
H. Sung, H. B. Shin, M.-N. Kim, K. Lee, E.-C. Kim, W. Song, S. H. Jeong, W.-G. Lee, Y.-J. Park, and G. M. Eliopoulos
Vancomycin-Tolerant Streptococcus pneumoniae in Korea.
J. Clin. Microbiol., October 1, 2006; 44(10): 3524 - 3528.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
W. Haas, D. Kaushal, J. Sublett, C. Obert, and E. I. Tuomanen
Vancomycin Stress Response in a Sensitive and a Tolerant Strain of Streptococcus pneumoniae
J. Bacteriol., December 1, 2005; 187(23): 8205 - 8210.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
W. Haas, J. Sublett, D. Kaushal, and E. I. Tuomanen
Revising the Role of the Pneumococcal vex-vncRS Locus in Vancomycin Tolerance
J. Bacteriol., December 15, 2004; 186(24): 8463 - 8471.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.